Marleen Bakker

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Gitte Berkers, Peter van Mourik, Annelotte M. Vonk et al. · Cell Reports · 2019 · 310 citations · Full text

Medicine, Cell Biology, Pharmacology +16

The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy

M. Stegeman, Marissa Louwen, Jacobus van der Velden et al. · Gynecologic Oncology · 2007 · 155 citations

Medicine, Oncology, Surgery +5

Clinical Manifestations of Patients With Intraocular Inflammation and Positive QuantiFERON–TB Gold In-Tube Test in a Country Nonendemic for Tuberculosis

Rina La Distia Nora, Mirjam E. J. van Velthoven, Ninette H. ten Dam‐van Loon et al. · American Journal of Ophthalmology · 2013 · 92 citations

Public Health, Infectious Diseases, Ophthalmology +15

Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients

Rogier A.S. Hoek, Marthe S. Paats, Suzan D. Pas et al. · Scandinavian Journal of Infectious Diseases · 2012 · 91 citations

Life Sciences, Infectious Diseases, Microbiology +17